Vagner Rigaud

Dr. Vagner Rigaud

Temple University School of Medicine,
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in JACC
Verified
Journal Article
Closed access
MAMônica Samuel Avila
Mônica Samuel Avila
SASilvia Moreira Ayub-Ferreira
Silvia Moreira Ayub-Ferreira
MWMauro Rogerio de Barros Wanderley
Mauro Rogerio de Barros Wanderley
FCFatima das Dores Cruz
Fatima das Dores Cruz
SBSara Michelly Gonçalves Brandão
Sara Michelly Gonçalves Brandão
EBEdimar Alcides Bocchi
Edimar Alcides Bocchi

29 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
VRVagner Oliveira-Carvalho Rigaud
Vagner Oliveira-Carvalho Rigaud
LFLudmila R.P. Ferreira
Ludmila R.P. Ferreira
SASilvia M. Ayub-Ferreira
Silvia M. Ayub-Ferreira
MÁMônica S. Ávila
Mônica S. Ávila
SBSara M.G. Brandão
Sara M.G. Brandão
EBEdimar A. Bocchi
Edimar A. Bocchi
Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients

1 January 2013 in DNA and Cell Biology
Verified
Journal Article
Closed access
VCVitor Oliveira Carvalho
Vitor Oliveira Carvalho
EBEdimar Alcides Bocchi
Edimar Alcides Bocchi
MicroRNAs (miRNAs) are a class of regulatory small RNAs that have fundamentally transformed our understanding of how gene networks are regulated representing one of the most exciting areas of the modern cardiology research. Among all known miRNAs, miR-208a is one of the most important heart-enriched miRNA playing a crucial role in the heart health and disease. miR-208a is a member of a miRNA family that also included miR-208b and is encoded by an intronic region of the Myh6 gene. Within the heart, miR-208a and miR-208b are involved in the regulation of the myosin heavy chain isoformswitch during development and in pathophysiological conditions. miR-208a is sufficient to induce arrhythmias, cardiac remodeling, and to regulate the expression of hypertrophy pathway components and the cardiac conduction system. Recently, the identification of miR-208a in the bloodstream has led to a great clinical interest to use this molecule as a potential noninvasive biomarker of myocardial injuries.

15 December 2012 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
VOVagner Oliveira-Carvalho
Vagner Oliveira-Carvalho
MSMiguel Morita Fernandes da Silva
Miguel Morita Fernandes da Silva
GGGuilherme Guimarães
Guilherme Guimarães
FBFernando Bacal
Fernando Bacal
EBEdimar Alcides Bocchi
Edimar Alcides Bocchi

30 May 2017 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
LLLaurie Laugier
Laurie Laugier
AFAmanda Farage Frade
Amanda Farage Frade
FFFrederico Moraes Ferreira
Frederico Moraes Ferreira
MBMonique Andrade Baron
Monique Andrade Baron
PTPriscila Camillo Teixeira
Priscila Camillo Teixeira
CCChristophe Chevillard
Christophe Chevillard
Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America and affects 10 million people worldwide. Approximately 12000 deaths attributable to Chagas disease occur annually due to chronic Chagas disease cardiomyopathy (CCC), an inflammatory cardiomyopathy presenting with heart failure and arrythmia; 30% of infected subjects develop CCC years after infection. Genetic mechanisms play a role in differential progression to CCC, but little is known about the role of epigenetic modifications in pathological gene expression patterns in CCC patients’ myocardium. DNA methylation is the most common modification in the mammalian genome. We investigated the impact of genome-wide cardiac DNA methylation on global gene expression in myocardial samples from end-stage CCC patients, compared to control samples from organ donors. In total, 4720 genes were differentially methylated between CCC patients and controls, of which 399 were also differentially expressed. Several of them were related to heart function or to the immune response and had methylation sites in their promoter region. Reporter gene and in silico transcription factor binding analyses indicated promoter methylation modified expression of key genes. Among those, we found potassium channel genes KCNA4 and KCNIP4, involved in electrical conduction and arrythmia, SMOC2, involved in matrix remodeling, as well as enkephalin and RUNX3, potentially involved in the increased T-helper 1 cytokine-mediated inflammatory damage in heart. Results support that DNA methylation plays a role in the regulation of expression of pathogenically relevant genes in CCC myocardium, and identify novel potential disease pathways and therapeutic targets in CCC.

21 December 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RFRodrigues Ferreira
Rodrigues Ferreira
FFFrederico Moraes Ferreira
Frederico Moraes Ferreira
LLLaurie Laugier
Laurie Laugier
SCSandrine Cabantous
Sandrine Cabantous
INIsabela Cunha Navarro
Isabela Cunha Navarro
ECEdecio Cunha-Neto
Edecio Cunha-Neto
Chagas disease, caused by the parasite Trypanosoma cruzi, is endemic in Latin America. Its acute phase is associated with high parasitism, myocarditis and profound myocardial gene expression changes. A chronic phase ensues where 30% develop severe heart lesions. Mouse models of T. cruzi infection have been used to study heart damage in Chagas disease. The aim of this study was to provide an interactome between miRNAs and their targetome in Chagas heart disease by integrating gene and microRNA expression profiling data from hearts of T. cruzi infected mice. Gene expression profiling revealed enrichment in biological processes and pathways associated with immune response and metabolism. Pathways, functional and upstream regulator analysis of the intersections between predicted targets of differentially expressed microRNAs and differentially expressed mRNAs revealed enrichment in biological processes and pathways such as IFNγ, TNFα, NF-kB signaling signatures, CTL-mediated apoptosis, mitochondrial dysfunction, and Nrf2-modulated antioxidative responses. We also observed enrichment in other key heart disease-related processes like myocarditis, fibrosis, hypertrophy and arrhythmia. Our correlation study suggests that miRNAs may be implicated in the pathophysiological processes taking place the hearts of acutely T. cruzi-infected mice.